Search
-
Antitumor Assessment
… Job Title Clinical Research Coordinator Focus in the Core: PDX Education BS, Lafayette College Degree BS Start Year 2021 Email [email protected] Lab Phone 646-888-2142 Office Phone 646-888-3547
-
Department of Medical Physics
Our physicists, engineers, and staff advance the science and technology of radiation therapy and imaging, and ensure their effective clinical use for cancer patients.
… Our physicists, engineers, and staff advance the science and technology of radiation therapy and imaging, and ensure their effective clinical use for cancer patients. About Us The Department of Medical Physics is actively developing new methods to address a wide range of imaging, radiotherapy, and engineering
-
The Department of Radiation Oncology at Memorial Sloan Kettering (MSK) invites high school and undergraduate students to apply for our Educational Internship Program. This program offers an immersive, non-clinical experience in a world-renowned cancer translational environment.
… Educational Internship Program: Department of Radiation Oncology The Department of Radiation Oncology at Memorial Sloan Kettering (MSK) invites high school and undergraduate students to apply for our Educational Internship Program. This program offers an immersive, non-clinical experience in a world-renowned
-
Josie Robertson Surgery Center Art Walk
Explore the Josie Robertson Surgery Center 3rd Floor Art Walk, move from piece to piece and learn each one’s story from the individual artist.
… Josie Robertson Surgery Center 3rd Floor Art Walk Please use this map to help guide you around to different works of art on the 3rd floor. Begin exploring Back to welcome page “It is my sincere hope that this art collection and the guided art walks we offer will be an inspirational part of your journey
-
News
Within moments of speaking with Lucy Fleming, you notice she is always smiling. It’s a bright smile that radiates warmth. Lucy channels this positive energy as manager of the Patient Access Service at Memorial Sloan Kettering Cancer Center (MSK).
… Tuesday, June 7, 2022 Lucy with her family Lucy with her family Within moments of speaking with Lucy Fleming, you notice she is always smiling. It’s a bright smile that radiates warmth. Lucy channels this positive energy as manager of the Patient Access Service at Memorial Sloan Kettering Cancer Center
-
Meet the team behind MSK News, which publishes each spring and fall.
… The MSK News Team EXECUTIVE VICE PRESIDENT, CHIEF MARKETING & COMMUNICATION OFFICER Erin McDonough, MBA SENIOR VICE PRESIDENT & CHIEF DEVELOPMENT OFFICER Ken Manotti CHIEF CONTENT OFFICER Ami Schmitz SENIOR DIRECTOR, EDITORIAL Katie Sobolik MANAGING EDITOR Bill Piersol CREATIVE DIRECTOR Randi Press ASSOCIATE
-
I’m a nurse practitioner who provides care for people with urological cancers. This includes prostate cancer, bladder cancer, and kidney cancer. I see patients at the Sidney Kimmel Center for Prostate and Urologic Cancers.
… Job Title Nurse Practitioner I’m a nurse practitioner with more than 5 years of experience in caring for people with urological cancers. This includes prostate cancer , bladder cancer , and kidney cancer . At Memorial Sloan Kettering Cancer Center (MSK), I provide support to patients and help them understand
-
The Christine Iacobuzio-Donahue Lab
… Job Title Senior Research Technician Email [email protected]
-
News
Learn about what DNA repair looks like under a microscope.
… Friday, May 19, 2017 Summary When DNA is damaged, a cell stops dividing and recruits “lifeguard proteins” and repair proteins to get its life cycle back on track. The first microscope was invented almost 500 years ago, when two Dutch scientists placed lenses in a tube and found that they could magnify
-
News
MSK investigators report exciting results for a new molecule that can block 16 different mutated forms of the KRAS protein. In the lab, the compound was effective against many cancer cell lines and in mouse models of lung cancer and colorectal cancer.
… Wednesday, May 31, 2023 KRAS was one of the first cancer genes ever discovered, but for a long time the cancer-causing KRAS protein was considered “undruggable” with targeted therapy. That started to change in May 2021, when the Food and Drug Administration granted accelerated approval to sotorasib (